Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Risk-adapted therapy in smoldering myeloma

In this video, Maria-Victoria Mateos, MD, PhD, from the University of Salamanca, Salamanca, Spain, expresses the importance of risk-adapted therapy in myeloma. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.